Citigroup Inc Amyris, Inc. Transaction History

Citigroup Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$0.58 - $1.3 $55,028 - $123,340	94,877 Added 803.02%	106,692 $109,000
Q1 2023 May 11, 2023	BUY	$1.09 - $1.82 $2,260 - $3,774	2,074 Added 21.29%	11,815 $16,000
Q4 2022 Feb 09, 2023	BUY	$1.52 - $3.39 $3,511 - $7,830	2,310 Added 31.09%	9,741 $14,000
Q3 2022 Nov 10, 2022	SELL	$1.7 - $4.05 $19,317 - $46,020	-11,363 Reduced 60.46%	7,431 $21,000
Q2 2022 Aug 10, 2022	BUY	$1.6 - $5.07 $8,803 - $27,895	5,502 Added 41.39%	18,794 $35,000
Q1 2022 May 12, 2022	SELL	$3.92 - $5.86 $198,089 - $296,123	-50,533 Reduced 79.17%	13,292 $58,000
Q4 2021 Feb 10, 2022	BUY	$5.0 - $14.85 $202,685 - $601,974	40,537 Added 174.07%	63,825 $345,000
Q3 2021 Nov 10, 2021	BUY	$12.13 - $16.99 $282,483 - $395,663	23,288 New	23,288 $320,000

230K

Ticker AMRS
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 324,860,000
Market Cap $3.25M
Description
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.